Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy

Abstract We present an approach to quantify drug–target engagement using in vivo fluorescence endomicroscopy, validated with in vitro measurements. Doxorubicin binding to chromatin changes the fluorescence lifetime of histone-GFP fusions that we measure in vivo at single-cell resolution using a conf...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hugh Sparks, Hiroshi Kondo, Steven Hooper, Ian Munro, Gordon T. Kennedy, Christopher Dunsby, Paul M. W. French, Erik Sahai
Format: Artigo
Langue:anglais
Publié: 2018
Accès en ligne:https://doi.org/10.1038/s41467-018-04820-6
https://www.nature.com/articles/s41467-018-04820-6.pdf
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!